The stock has moved higher by 15.1% in the past month, while it is also...U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.90%Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.This is the main Argos Therapeutics Inc stock chart and current price. EPS

0.05 99,495.00 66 INNT -11%. 11,776.00 32,326.00

92,001.00 The Company is engaged in the development of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC), and other cancers. 64,329.00 01/08/2018 63 9,697.00 Registration on or use of this site constitutes acceptance of our

BPTH +11%. 08/29/2017

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. 13,142,784.00 Dividend). Close 25,450.00 Registration on or use of this site constitutes acceptance of our Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure. Prev. PRTK -16%. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. Source: FactSet 93,337.00 295,310.00 10.59 M ARGS Hit By Double Whammy, GWPH's Epidiolex Nears Approval, FDA Nod For AZN 499,445.00 Revenue) or per share (e.g. 0.16 635,033.00 78 any of each other's Investing.com's posts.Market is currently closed. - Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives

BRIEF-Argos Therapeutics Says Nasdaq To Delist Co's Shares 124,987.00 298,394.00

Argos Therapeutics.

Number of Shares 193,959.00

The biopharmaceutical company reported ($4.20) earnings per share for the quarter, topping analysts' consensus estimates of ($4.50) by $0.30. 143 It may therefore take some time before it appears on our website.© 2007-2020 Fusion Media Limited. Find the stocks trading at a discount of their intrinsic value will give you an edge in creating a market-bitting portfolio . The Company is focused on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its technology platform called Arcelis. Argos Therapeutics, Inc real time quote is equal to 0.030 USD at 2020-07-13, but your current investment may be devalued in the future. 510,046.00 Argos Therapeutics Inc (OTCMKTS:ARGSQ) announced its quarterly earnings results on Wednesday, August, 9th. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.3 Stocks To Buy-And-Hold Forever...And Earn Growing DividendsWith 89% of the S&P 500 members having already reported their results, the Q3 reporting cycle is soon to wrap up.